Details for Patent: 9,474,752
✉ Email this page to a colleague
Which drugs does patent 9,474,752 protect, and when does it expire?
Patent 9,474,752 protects LETAIRIS and is included in one NDA.
This patent has seventeen patent family members in fourteen countries.
Summary for Patent: 9,474,752
| Title: | Method for treating a pulmonary hypertension condition |
| Abstract: | A method for treating a pulmonary hypertension condition such as pulmonary arterial hypertension (PAH) in a subject comprises administering to the subject a therapeutically effective amount of ambrisentan, wherein, at baseline, time from first diagnosis of the condition in the subject is not greater than about 2 years. |
| Inventor(s): | Michael J. Gerber, Christopher Dufton |
| Assignee: | Gilead Sciences Inc |
| Application Number: | US14/182,208 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,474,752 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent 9,474,752
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gilead | LETAIRIS | ambrisentan | TABLET;ORAL | 022081-001 | Jun 15, 2007 | AB | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL | ⤷ Start Trial | |||
| Gilead | LETAIRIS | ambrisentan | TABLET;ORAL | 022081-002 | Jun 15, 2007 | AB | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,474,752
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2101777 | ⤷ Start Trial | 300813 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2101777 | ⤷ Start Trial | PA2016018 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2101777 | ⤷ Start Trial | 93081 | Luxembourg | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
